WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ:330350)
9,150.00
0.00 (0.00%)
At close: Apr 28, 2026
KOSDAQ:330350 Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 120,800 | 113,802 | 92,943 | 128,366 | 123,616 | 138,481 | Upgrade
|
| Market Cap Growth | 51.49% | 22.44% | -27.59% | 3.84% | -10.73% | -26.91% | Upgrade
|
| Enterprise Value | 120,084 | 114,670 | 101,308 | 130,632 | 113,324 | 119,353 | Upgrade
|
| Last Close Price | 9150.00 | 8620.00 | 7040.00 | 9730.00 | 9270.64 | 10388.65 | Upgrade
|
| PE Ratio | 24.34 | 22.91 | 19.43 | 16.13 | 49.86 | 32.48 | Upgrade
|
| PS Ratio | 1.13 | 1.07 | 0.91 | 1.60 | 1.91 | 2.41 | Upgrade
|
| PB Ratio | 1.23 | 1.16 | 1.00 | 1.42 | 1.49 | 1.71 | Upgrade
|
| P/TBV Ratio | 1.29 | 1.22 | 1.05 | 1.46 | 1.54 | 1.75 | Upgrade
|
| P/FCF Ratio | 22.03 | 20.76 | 12.79 | - | - | 102.25 | Upgrade
|
| P/OCF Ratio | 17.81 | 16.78 | 9.65 | - | 22.98 | 17.27 | Upgrade
|
| EV/Sales Ratio | 1.13 | 1.08 | 0.99 | 1.63 | 1.75 | 2.08 | Upgrade
|
| EV/EBITDA Ratio | 12.32 | 11.77 | 10.73 | 12.15 | 16.60 | 18.69 | Upgrade
|
| EV/EBIT Ratio | 21.21 | 20.25 | 17.90 | 16.52 | 23.23 | 24.43 | Upgrade
|
| EV/FCF Ratio | 21.90 | 20.91 | 13.94 | - | - | 88.13 | Upgrade
|
| Debt / Equity Ratio | 0.19 | 0.19 | 0.26 | 0.22 | 0.26 | 0.29 | Upgrade
|
| Debt / EBITDA Ratio | 1.92 | 1.92 | 2.55 | 1.86 | 3.14 | 3.62 | Upgrade
|
| Debt / FCF Ratio | 3.42 | 3.42 | 3.31 | - | - | 17.06 | Upgrade
|
| Net Debt / Equity Ratio | -0.01 | -0.01 | 0.06 | 0.10 | -0.06 | -0.24 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.07 | -0.07 | 0.55 | 0.82 | -0.75 | -3.03 | Upgrade
|
| Net Debt / FCF Ratio | -0.13 | -0.13 | 0.71 | -0.73 | 0.51 | -14.30 | Upgrade
|
| Asset Turnover | 0.79 | 0.79 | 0.77 | 0.64 | 0.54 | 0.51 | Upgrade
|
| Inventory Turnover | 2.14 | 2.14 | 2.31 | 2.52 | 3.07 | 2.98 | Upgrade
|
| Quick Ratio | 1.37 | 1.37 | 1.21 | 1.20 | 1.74 | 2.55 | Upgrade
|
| Current Ratio | 2.06 | 2.06 | 1.80 | 1.88 | 2.33 | 3.19 | Upgrade
|
| Return on Equity (ROE) | 5.20% | 5.20% | 5.22% | 9.19% | 3.02% | 5.41% | Upgrade
|
| Return on Assets (ROA) | 2.61% | 2.61% | 2.67% | 3.95% | 2.56% | 2.71% | Upgrade
|
| Return on Invested Capital (ROIC) | 5.77% | 5.79% | 5.34% | 7.78% | 4.17% | 6.84% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.50% | 5.50% | 5.60% | 7.90% | 5.20% | 5.10% | Upgrade
|
| Earnings Yield | 4.11% | 4.37% | 5.15% | 6.20% | 2.01% | 3.08% | Upgrade
|
| FCF Yield | 4.54% | 4.82% | 7.82% | -9.38% | -8.05% | 0.98% | Upgrade
|
| Payout Ratio | - | - | 27.57% | - | 25.53% | 9.90% | Upgrade
|
| Buyback Yield / Dilution | 0.05% | 0.05% | -0.21% | -0.03% | 0.10% | -59.55% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.